Pell Bio-Med Technology Co., Ltd. (TPE:6949)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
45.35
-4.15 (-8.38%)
Nov 17, 2026, 1:30 PM CST

Pell Bio-Med Technology Income Statement

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
32.3331.4219.6318.0317.1613.98
Revenue Growth
7.80%60.07%8.86%5.11%22.75%-
Cost of Revenue
42.4935.8231.9644.1728.4118.35
Gross Profit
-10.15-4.39-12.33-26.14-11.26-4.37
Selling, General & Admin
256.51210.3135.01145.4982.2454.78
Research & Development
206.43252.66266.16239.61142.55136.82
Operating Expenses
462.94462.96401.17385.11224.85191.59
Operating Income
-473.09-467.35-413.5-411.25-236.11-195.96
Interest Expense
-0.48-2.05-2.26-2.56-1.36-1.52
Interest & Investment Income
20.8911.9115.377.632.270.24
Earnings From Equity Investments
0-00.110.11-00.01
Currency Exchange Gain (Loss)
-1.32-1.320.10.091.52-0.51
Other Non Operating Income (Expenses)
-8.381.015.824.862.418.97
EBT Excluding Unusual Items
-462.39-457.8-394.36-401.11-231.27-188.76
Gain (Loss) on Sale of Investments
5.135.13-0.62---
Gain (Loss) on Sale of Assets
---0.14-0.13--0.2
Pretax Income
-457.26-452.67-395.12-401.24-231.27-188.96
Income Tax Expense
---0--
Earnings From Continuing Operations
-457.26-452.67-395.12-401.24-231.27-188.96
Minority Interest in Earnings
48.9828.735.72.481.14-
Net Income
-408.27-423.94-389.42-398.76-230.13-188.96
Net Income to Common
-408.27-423.94-389.42-398.76-230.13-188.96
Net Income Growth
------
Shares Outstanding (Basic)
1,2471,1731,141925784666
Shares Outstanding (Diluted)
1,2471,1731,141925784666
Shares Change
6.48%2.77%23.33%17.94%17.87%-
EPS (Basic)
-0.33-0.36-0.34-0.43-0.29-0.28
EPS (Diluted)
-0.33-0.36-0.34-0.43-0.29-0.28
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-608.37-507.7-523.91-196.48-167.48-122.32
Free Cash Flow Per Share
-0.49-0.43-0.46-0.21-0.21-0.18
Gross Margin
-31.40%-13.97%-62.79%-144.96%-65.61%-31.27%
Operating Margin
-1463.15%-1487.24%-2106.35%-2280.52%-1376.17%-1402.03%
Profit Margin
-1262.67%-1349.09%-1983.67%-2211.26%-1341.32%-1351.93%
Free Cash Flow Margin
-1881.52%-1615.65%-2668.77%-1089.53%-976.14%-875.12%
EBITDA
-426.77-448.36-394.04-392.04-217.36-178.32
D&A For EBITDA
46.3218.9919.4619.2118.7517.65
EBIT
-473.09-467.35-413.5-411.25-236.11-195.96